This compound is a fluorinated derivative of prasugrel, used as an intermediate in the synthesis of pharmaceutical products. Its structure includes a thienopyridine ring system and a cyclopropyl carbonyl group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1391194-39-0
4-Fluoro prasugrel
pharmaceutical intermediate
Prasugrel
platelet aggregation inhibitor
Prasugrel hydrochloride
active pharmaceutical ingredient
Folic Acid EP Impurity F
Folic acid impurity reference standard
4-(2-Hydroxyethyl)indolin-2-one
Pharmaceutical intermediate for indole derivatives
(2R,3R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid
Peptide synthesis building block
(2R,4S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-(((dimethylamino)methylene)amino)-6-oxo-1H-purin-9(6H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Nucleoside phosphoramidite building block
(+/-)-Prasugrel-d3 (acetate-d3)
active pharmaceutical ingredient
[5-[2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate
IMTFHRNDRHBYGI-UHFFFAOYSA-N
CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC(=CC=C3)F)C(=O)C4CC4